These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4737120)

  • 1. [Case of long term administration of anti-cholinesterase preparations, with special reference to problems of the neuromuscular endplate].
    Segawa M
    Nihon Rinsho; 1973 Feb; 31(2):364-9. PubMed ID: 4737120
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems of long term administration of anti-cholinesterase preparations in myasthenia gravis].
    Ishikawa S; Mukuno K
    Nihon Rinsho; 1973 Feb; 31(2):359-63. PubMed ID: 4737119
    [No Abstract]   [Full Text] [Related]  

  • 3. Lens findings in patients with myasthenia gravis on long-term treatment with oral anticholinesterases.
    Lieberman TW; Leopold IH; Osserman KE; Hyams L
    Mt Sinai J Med; 1971; 38(3):324-31. PubMed ID: 5314217
    [No Abstract]   [Full Text] [Related]  

  • 4. Myasthenia gravis: medical, surgical and anesthetic considerations.
    Vautrinot B
    AANA J; 1979 Aug; 47(4):431-41. PubMed ID: 495032
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis.
    Brown JC; Johns RJ
    Johns Hopkins Med J; 1969 Jan; 124(1):1-8. PubMed ID: 5762895
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibiotics and myasthenia gravis].
    Igata A
    Shinkei Kenkyu No Shimpo; 1971; 15(4):910-3. PubMed ID: 5168643
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems of antibiotic administration in myasthenia gravis].
    Onishi A; Shida K; Kuroiwa Y
    Shinkei Kenkyu No Shimpo; 1971; 15(4):906-10. PubMed ID: 4334475
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacological basis for the treatment of myasthenia gravis.
    Flacke W
    Pharmacol Physicians; 1970 Jun; 4(6):1-7. PubMed ID: 4316342
    [No Abstract]   [Full Text] [Related]  

  • 9. Myasthenia gravis: an overview.
    Dreilinger CL
    Ophthalmic Semin; 1976; 1(2):101-33. PubMed ID: 799277
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Grob test in myasthenia: discussion of an atypical case].
    Gambi D; Tonali P
    Riv Neurol; 1971; 41(3):161-9. PubMed ID: 4331238
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse interaction between corticosteroid hormones and anticholinesterase drugs.
    Patten BM; Oliver KL; Engel WK
    Trans Am Neurol Assoc; 1973; 98():248-52. PubMed ID: 4784943
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of intermittent noninvasive ventilation in anticholinesterase dose adjustment for myasthenic crisis.
    Mishra SK; Krishnappa S; Bhat RR; Badhe A
    Acta Anaesthesiol Taiwan; 2010 Mar; 48(1):53-4. PubMed ID: 20434116
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects on neuromuscular function of acute chronic exposure to cholinesterase inhibitors in man and in the rat.
    Roberts DV; Taylor K; Wilson A
    J Physiol; 1971 Dec; 219(2):15P. PubMed ID: 4333825
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myasthenia gravis].
    Elmqvist D
    Lakartidningen; 1966 Apr; 63(14):1353-62. PubMed ID: 4223911
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cholinergic crisis of childhood myasthenia gravis].
    Segawa M
    Shinkei Kenkyu No Shimpo; 1971; 15(4):874-6. PubMed ID: 5168636
    [No Abstract]   [Full Text] [Related]  

  • 16. [Crisis in myasthenia gravis in infancy and childhood].
    Mitsudome A; Takeshita K; Matsumoto T
    Shinkei Kenkyu No Shimpo; 1971; 15(4):871-4. PubMed ID: 5168635
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism of action of muscle relaxants and its clinical problems].
    Suzuki H
    Masui; 1974 Aug; 23(8):679-92. PubMed ID: 4372420
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
    Punga AR; Flink R; Askmark H; Stålberg EV
    Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of myasthenia gravis.
    Dipalma JR
    Am Fam Physician; 1980 Oct; 22(4):158-9. PubMed ID: 7424763
    [No Abstract]   [Full Text] [Related]  

  • 20. Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial.
    Sieb JP; Köhler W
    Clin Neurol Neurosurg; 2010 Nov; 112(9):781-4. PubMed ID: 20663605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.